Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis

被引：0
|
作者：
J. Hiltunen
P. Parmanne
T. Sokka
T. Lamberg
P. Isomäki
O. Kaipiainen-Seppänen
R. Peltomaa
T. Uutela
L. Pirilä
K. Taimen
M. J. Kauppi
T. Yli-Kerttula
R. Tuompo
H. Relas
S. Kortelainen
K. Paalanen
J. Asikainen
P. Ekman
A. Santisteban
K.-L. Vidqvist
K. Tadesse
M. Romu
J. Borodina
P. Elfving
H. Valleala
M. Leirisalo-Repo
V. Rantalaiho
H. Kautiainen
T. S. Jokiranta
K. K. Eklund
机构：
[1] Helsinki University and Helsinki University Hospital,Department of Rheumatology
[2] Jyväskylä Central Hospital,Department of Rheumatology
[3] University of Eastern Finland,Department of Rheumatology
[4] United Medix Laboratories,Department of Rheumatology
[5] Tampere University Hospital,Department of Rheumatology
[6] Kuopio University Hospital,Department of Rheumatology
[7] Central Hospital of Lapland,Department of Rheumatology
[8] Turku University Hospital,Department of Rheumatology
[9] Päijät-Häme Central Hospital,Translational Immunology Research Program
[10] University of Tampere,Department of Rheumatology
[11] Satakunta Central Hospital,undefined
[12] Medcare Foundation,undefined
[13] SYNLAB Finland,undefined
[14] Helsinki University and Orton Research Foundation,undefined
[15] Orton Hospital,undefined
[16] Mikkeli Central Hospital,undefined
来源：
Rheumatology International | 2022年 / 42卷
关键词：
Spondyloarthritis; Ankylosing spondylitis; Biological therapy; Anti-drug antibodies; Disease activity; Therapeutic drug monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1025
页数：10
相关论文
共 50 条
  • [41] Clinical impact of direct oral anticoagulant measuring in a real-life setting
    Winther-Larsen, Anne
    Hvas, Anne-Mette
    THROMBOSIS RESEARCH, 2019, 175 : 40 - 45
  • [42] An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting
    Blanco-Dorado, Sara
    Cea-Arestin, Cristina
    Gonzalez Carballo, Alba
    Latorre-Pellicer, Ana
    Maronas Amigo, Olalla
    Barbeito Castineiras, Gema
    del Molino Bernal, Maria Luisa Perez
    Campos-Toimil, Manuel
    Fernandez-Ferreiro, Anxo
    Lamas, Maria J.
    JOURNAL OF CHEMOTHERAPY, 2019, 31 (01) : 49 - 57
  • [43] QUALITY OF LIFE OF STROKE PATIENTS AFTER ENDOVASCULAR TREATMENT IN A REAL-LIFE SETTING
    Araujo, A.
    Miranda, A.
    Novo, J.
    Rodrigues, M.
    Castro, S.
    Gregorio, T.
    Veloso, M.
    Barros, P.
    Pinho, J.
    Ribeiro, M.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 89 - 89
  • [44] CLINICAL USE OF PER IN REAL-LIFE CLINICAL SETTING: A RETROSPECTIVE STUDY IN PATIENTS WITH "SUPER-REFRACTORY" EPILEPSIES
    Fattouch, J.
    Albini, M.
    Fanella, M.
    Morano, A.
    Casciato, S.
    Basili, L. M.
    Mascia, A.
    D'Aniello, A.
    Quarato, P. P.
    Manfredi, M.
    Giallonardo, A. T.
    Di Gennaro, G.
    Di Bonaventura, C.
    EPILEPSIA, 2016, 57 : 174 - 174
  • [45] In real-life learning, what is meant by 'real'? The concept of reality and its significance to IS curriculum
    Tatnall, A
    Information and Communication Technologies and Real-Life Learning: NEW EDUCATION FOR THE KNOWLEDGE SOCIETY, 2005, 182 : 143 - 150
  • [46] DERMATOLOGIC ADVERSE EVENTS IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS USING ANTI-TNF THERAPY IN A REAL-LIFE SETTING
    Real, A. P.
    Palomino, A.
    Villarreal, L.
    Bello, J.
    Santos-Moreno, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 872 - 872
  • [47] Pazopanib for patients with advanced soft tissue sarcomas in a real-life setting
    Sleijfer, Stefan
    CANCER, 2016, 122 (09) : 1346 - 1348
  • [48] REAL-LIFE ANALYSIS ON SURVIVAL TO TREATMENT AND REASONS FOR SWITCHING OF BIOLOGICAL DMARDS IN PATIENTS WITH SPONDYLOARTHRITIS
    Di Sanzo, L.
    Molteni, E.
    Castellani, C.
    Bevignani, G.
    Sciarra, G.
    Di Franco, M.
    Riccieri, V.
    Alessandri, C.
    Scrivo, R.
    Conti, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1688 - 1688
  • [49] LOW DISEASE ACTIVITY IN REAL-LIFE PATIENTS WITH A DIAGNOSIS OF AXIAL SPONDYLOARTHRITIS: AN ACHIEVABLE TARGET?
    Ortolan, A.
    di Murro, S.
    Tur, C.
    Boni, V
    Rubortone, P.
    Capacci, A.
    Calabrese, G.
    Natalello, G.
    De Lorenzis, E.
    Peluso, G.
    D'Agostino, M. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 17 - 17
  • [50] Clinical and structural damage outcomes in axial spondyloarthritis patients receiving NSAIDs or advanced therapies: a description of a real-life cohort
    Mocritcaia, Anastasia
    Chacur, Chafik
    Abe, C. D. Adao
    Azuaga-Pinango, Ana Belen
    Frade-Sosa, Beatriz
    Sarmiento-Monroy, Juan C.
    Alascio, Lucia
    Gomez-Puerta, J. A.
    Sanmarti, Raimon
    Canete, Juan D.
    Ramirez, Julio
    FRONTIERS IN MEDICINE, 2024, 11
12345